Jon Thor Asmussen

4PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 15, 2024
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted

|Aug 28, 2023
A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.

Karen Middelbo Buch-Olsen, Mads Hvid Poulsen, Steinbjørn Hansen

|Mar 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 Study.

Marta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen

|Apr 12, 2022
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.

Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen

Pageof 1

Frequent Collaborators

2 joint publications

Thomas Lund

1 joint publications

Birgitte Bjørnhart

1 joint publications

Jørn Herrstedt

1 joint publications

Tine Schytte